Impaired immune reconstitution post sequential high-dose chemotherapy and peripheral blood progenitor cell (PBPC) infusion.

被引：0
|
作者：
Stein, DT
Mackall, CL
Bare, CV
Brown, MR
Carter, CS
Casey, N
Yu, MY
Fleisher, TA
Leitman, SF
Shearer, GM
Wexler, L
Gress, RE
机构：
[1] NCI,DEPT TRANSFUS MED,BETHESDA,MD 20892
[2] NIH,DEPT CLIN PATHOL,BETHESDA,MD 20892
来源：
PEDIATRIC RESEARCH | 1996年 / 39卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：962 / 962
页数：1
相关论文
共 50 条
  • [1] Impaired immune reconstitution post sequential high dose chemotherapy and peripheral blood progenitor cell (PBPC) infusion.
    Stein, D
    Mackall, C
    Bare, C
    Brown, M
    Carter, C
    Casey, N
    Yu, M
    Fleisher, T
    Leitman, S
    Shearer, G
    Wexler, L
    Gress, R
    BLOOD, 1995, 86 (10) : 402 - 402
  • [2] T-cell reconstitution following high dose sequential chemotherapy (HDS) with peripheral blood progenitor cell transplantation (PBPC-T) for malignancies.
    Da Prada, GA
    Montagna, D
    Maccario, R
    Moretta, A
    Zambelli, A
    Montini, E
    Pedrazzoli, P
    Locatelli, F
    della Cuna, GR
    BONE MARROW TRANSPLANTATION, 1999, 23 : S230 - S230
  • [3] HIGH-DOSE CHEMOTHERAPY (HDC) WITH PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) SUPPORT IN THE OUTPATIENT SETTING
    MICHELSON, GC
    GRINBLATT, D
    BYRNEMALLOY, R
    ZIMMERMAN, T
    WILLIAMS, SF
    CLINICAL RESEARCH, 1994, 42 (03): : A378 - A378
  • [4] High-dose sequential chemotherapy (HDSC) with peripheral blood progenitor cells (PBPC) support for high-risk breast cancer (BC)
    Sabbatini, R.
    Da Prada, G. A.
    Frassineti, G. L.
    Aietta, M.
    Pedrazzoli, P.
    Maur, M.
    Zambelli, A.
    Giovannini, N.
    Siena, S.
    Ponchio, L.
    Conte, P. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [5] Peripheral blood progenitor cell (PBPC) rescue following high dose chemotherapy in breast cancer: Satisfactory early haematopoietic reconstitution
    Eatock, M
    Cook, G
    Franklin, IM
    Tansey, P
    Soukop, M
    Dunlop, D
    BRITISH JOURNAL OF CANCER, 1996, 73 (08) : 25 - 25
  • [6] High-dose chemotherapy (HDC) with autologous peripheral blood progenitor cell (PBPC) support in patients with metastatic breast cancer
    Constenla, M
    Lorenzo, I
    Carrete, N
    Rey, C
    Campos, B
    Arroyo, FR
    Ozores, R
    Castro, A
    Solla, E
    Villascusa, R
    BONE MARROW TRANSPLANTATION, 1999, 23 : S40 - S40
  • [7] Mobilized peripheral blood progenitor cells (PBPC) in support of tandem cycles of high-dose chemotherapy (HDC)
    Meisenberg, BR
    Miller, WE
    McMillan, R
    BONE MARROW TRANSPLANTATION, 1996, 18 (06) : 1087 - 1093
  • [8] High-dose therapy with peripheral blood progenitor cell (PBPC) autografting in multiple myeloma (MM)
    Goldschmidt, H
    Hegenbart, U
    Wallmeier, M
    Fruehauf, S
    Hohaus, S
    Wannenmacher, M
    Haas, R
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 404 - 404
  • [9] EBMT randomized study of high-dose sequential chemotherapy (CT) supported by peripheral blood progenitor cells (PBPC) for the treatment of small cell lung cancer (SCLC)
    Leyvraz, Serge
    Pampallona, Sandro
    Martinelli, Giovanni
    Ferdinand, Ploner
    Aversa, Savina
    Rosti, Giovanni
    Brunsvig, Paal
    Montes, Ana
    Lange, Andrzej
    Yilmaz, Ugur
    ANNALS OF ONCOLOGY, 2006, 17 : 215 - 215
  • [10] High-dose therapy with peripheral blood progenitor cell support (PBPC) for the treatment of advanced breast cancer
    Fersis, N
    Haas, R
    Wallwiener, D
    Hohaus, S
    Huober, J
    Bastert, G
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 661 - 661
12345